Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report [PDF]
Journal of Medical Case Reports, 2012 Introduction The combination of polyethylene glycol (PEG)ylated interferon (pegylated interferon) and ribavirin has been shown to be an effective treatment for chronic hepatitis C virus. In general, common side effects related to this combination therapy
Lahbabi Mounia +4 more
doaj +2 more sources
Retrospective analysis of total direct medical costs associated with hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey [PDF]
, 2014 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108669/1/jvh12206 ...
Altinbas, A. +5 more
core +3 more sources
A Systematic Review and Model-Based Meta-Analysis of Pegylated-Interferon-α-Induced HBsAg Loss in Chronic Hepatitis B Virus Infection. [PDF]
CPT Pharmacometrics Syst PharmacolABSTRACT Pegylated‐interferon‐α (Peg‐IFNα) is a treatment option for chronic hepatitis B virus (HBV) infection. To quantify treatment response variability, we conducted a model‐based meta‐analysis (MBMA) of hepatitis B surface antigen (HBsAg) loss, defined as a binary outcome based on HBsAg levels falling below the limit of detection, with Peg‐IFNα ...
Hanan NJ +10 more
europepmc +2 more sources
Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and multidisciplinary clinical practice recommendations [PDF]
Therapeutic Advances in HematologyPegylated interferons alfa are increasingly used in patients with myeloproliferative neoplasms (MPN) due to their potential disease-modifying effect. Ropeginterferon alfa-2b has been approved for patients with polycythemia vera (PV) with no symptomatic ...
Axel Rüfer +7 more
doaj +2 more sources
Pegylated interferon: the who, why, and how. [PDF]
Hematology Am Soc Hematol Educ ProgramAbstract Interferon alpha (IFN-α) is a fascinating molecule with many biological properties yet to be fully understood. Among these properties, several have demonstrated usefulness for targeting malignant cells, including hematopoietic cells from patients with myeloproliferative neoplasms.
Kiladjian JJ.
europepmc +3 more sources
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A [PDF]
Pathology and Oncology ResearchIntroductionHairy cell leukemia (HCL) is an indolent B-cell lymphoproliferative disease. Interferon-alpha (IFN-alpha) was the first successfully used drug in HCL; its favourable effect has been known since the early 1980s.
Kata Ferenczi +6 more
doaj +2 more sources
Effect of Pegylated Interferon on Non-Responders and Relapsers with Interferon
Sultan Qaboos University Medical Journal, 2002 Objectives: To assess whether a combination of pegylated interferon (interferon conjugated with polyethylene glycol) and ribavirin can improve the response rate in patients with chronic hepatitis C who either did not respond to (Non-responders), or had ...
Hisham O. Akbar, Mahmoud S. Al Ahwal
doaj +3 more sources
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C [PDF]
, 2012 Background: To perform a comprehensive study on the relationship between vitamin D metabolism and the response to interferon-α-based therapy of chronic hepatitis C.
Badenhoop, Klaus +20 more
core +20 more sources
Machine learning model for HBsAg seroclearance after 48-week pegylated interferon therapy in inactive HBsAg carriers: a retrospective study. [PDF]
Virol JDong J +17 more
europepmc +2 more sources
Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir. [PDF]
Indian J Nephrol, 2023 Katiyar H +4 more
europepmc +2 more sources